FDA Awaits Word On Commissioner McClellan; Is He Headed To CMS?
This article was originally published in The Tan Sheet
The public speculation about FDA Commissioner McClellan's next move within the Bush Administration indicates the importance of the Medicare prescription drug bill to the White House heading into the November elections
You may also be interested in...
Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches
The appointment of former Virginia Tech Center for Food & Nutrition Policy head Lester Crawford, PhD/DVM, as acting commissioner puts FDA in the hands of HHS Secretary Tommy Thompson's preferred choice to lead the agency
Perrigo promotes in pricing, planning